Shaking creates foam that makes volume measurements inaccurate and can damage the peptide structure
Healthy cells maintain a ratio of 100:1 or higher (99% GSH, 100:1 The reality is that glutathione declines with age-by age 60, levels can be 30-50% lower than in youth
13 In addition to being recommended in patients with ASCVD, GLP-1 receptor agonists are recommended for consideration as an add-on to metformin in patients without established ASCVD in whom there is a compelling need to minimize hypoglycemia, minimize weight gain, or promote weight loss
"People can lose more fat." Retatrutide: Next-gen obesity drug helps patients lose 28% of body weight In a phase-three trial by Eli Lilly, patients on the highest dose lost an average of 28.3% of their body weight over a year and a half, and more than 45% of participants lost at least 30%, a level of efficacy the company said approaches results seen with bariatric surgery
Data were collected from a 20-week pilot trial (NCT05786521), which randomized 20 older adults (72.7 4.8 years of age, 50% women, 45% Hispanic) living with prediabetes/diabetes (hemoglobin A1C 5.7%7.5%) and overweight/obesity [body mass index (BMI): 32.9 4.0 kg/m 2 ] to 1.0 mg/weekly semaglutide + lifestyle counseling (n = 10) or lifestyle counseling alone (n = 10)
Red flags you should not ignore Difficulty swallowing (dysphagia): If food feels like it is getting stuck or you have trouble swallowing liquids, this could indicate esophageal narrowing from chronic acid exposure